Hbl-2 In Vitro PI Assay (Cell Viability)

CAT#: ITS-0123-YF3587
Target Cell Organism: Human
Target Cell Name: Hbl-2
Assay Type: Cell Viability/Cytotoxicity and Antiproliferative Assays
Assay Overview
This assay is to provide Hbl-2-based In Vitro PI Assay (Cell Viability) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
Hbl-2
Target Cell Organism
Human
Target Cell Background
The HBL-2 cell line is derived from an AIDS-SNCCL (AIDS-associated small non-cleaved cell lymphoma) patient. After immunophenotypic and molecular genetic analysis, the HBL-2 was established from the original tumor clones. The HBL-2 cell line presents surface immunoglobulin and B-cell restricted markers as well as a phenotype consistent with SNCCL; the cell line also displays clonal immunoglobulin gene rearrangement. The HBL-2 cell line is considered useful as a biological model to study AIDS-associated non-Hodgkin lymphomagenesis (AIDS-NHL) and the impacts of biological, immunological, and viral factors involved.
Related Diseases
Mantle Cell Lymphoma; MCL
Research Area
Oncology
Assay Name
In Vitro PI Assay (Cell Viability)
Assay Description
Propidium iodide (PI) is another dye that can be used to distinguish viable and non-viable cells. PI can only bind with DNA of cells with damaged cell membranes and it cannot enter viable cells. Uptake of PI into cells can be monitored by flow cytometry (FCM) or fluorescence microscopy.
Assay Alternative Names
Propidium Iodide Assay
Assay Type
Cell Viability/Cytotoxicity and Antiproliferative Assays
Assay Type Details
Uncontrolled proliferation is one of the main features of cancer cells. Cell-based in vitro assays are employed to determine whether test molecules possess direct cytotoxic/antiproliferative effects in cancer cells.
Assay Subtype
Cell Viability Assay
Assay MOA
Dye Exclusion Assays
For Research Use Only | Not For Clinical Use
Online Inquiry